Search results
1 day ago · AbbVie Inc. reported Q2 adjusted EPS of $2.65, beating the $2.57 consensus, with net revenues at $14.46 billion. Immunology sales rose to $6.97 billion, while Humira declined 29.8%. Oncology and ...
3 days ago · AbbVie (NYSE: ABBV), today announced that Canada's Drug Agency (CDA, formerly CADTH) has issued its first-ever Time-Limited Reimbursement (TLR)2 recommendation for EPKINLY (epcoritamab). This ...
1 day ago · AbbVie reported strong sales of its other medicines as demand for Humira fell because of competition from biosimilar drugs. Revenue from rheumatoid arthritis medicines Rinvoq and Skyrizi soared ...
1 day ago · 3.0 News and Social Media Coverage. News Sentiment AbbVie has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news).
8 hours ago · Notice. The "Yes" link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site.
4 days ago · AbbVie lines up Thakkar to replace outgoing CSO Hudson. There is change at the top of AbbVie’s R&D organisation, as chief scientific officer Thomas Hudson announces his retirement after four ...
21 hours ago · NORTH CHICAGO, Ill. — NORTH CHICAGO, Ill. — AbbVie Inc. (ABBV) on Thursday reported second-quarter earnings of $1.37 billion. The North Chicago, Illinois-based company said it had profit of 77 ...
